Received May 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Twinrix - Late second dose/received the first dose of Twinrix on Dec 18th 2025; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 66-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (1st dose received on 18-DEC-2025). The patient did not received the 2nd dose of Twinrix.The patient experienced incomplete course of vaccination (Verbatim: Twinrix - Late second dose/received the first dose of Twinrix on Dec 18th 2025). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 05-MAY-2026 The reporter asked how to complete the series. No further details were provided.